2022
DOI: 10.1016/j.canrad.2021.08.023
|View full text |Cite
|
Sign up to set email alerts
|

Adaptive radiation therapy: When, how and what are the benefits that literature provides?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 106 publications
0
15
0
Order By: Relevance
“…Therefore, it is more advantageous to treat patients with a moderate bladder protocol to ensure treatment repeatability and reduce toxicity (24,25). Although there was no significant difference in the rectum D mean between planned doses and merged CBCT-based accumulated doses (P<0.05), the has been reported as beneficial for patients with various diseases (26)(27)(28).…”
Section: Discussionmentioning
confidence: 98%
“…Therefore, it is more advantageous to treat patients with a moderate bladder protocol to ensure treatment repeatability and reduce toxicity (24,25). Although there was no significant difference in the rectum D mean between planned doses and merged CBCT-based accumulated doses (P<0.05), the has been reported as beneficial for patients with various diseases (26)(27)(28).…”
Section: Discussionmentioning
confidence: 98%
“…In the current literature, adaptation in radiotherapy for head and neck cancer seems quite timely and promising, especially in the era of image-guided radiotherapy. In a review study, Avgousti et al [ 37 ] evaluating 85 articles related to adaptive RT as an attempt to classify criteria for adaption, reported that the current thresholds which lead to replanning might be anatomical deviations > 1 cm in the external contour, average weight loss > 10%, violation in the dose coverage of the targets > 5%, and violation in the dose of the peripherals. However, beyond the expert opinion, a machine learning procedure seems more than necessary for routing clinical practice.…”
Section: Discussionmentioning
confidence: 99%
“…[10][11][12][13][14][15] Several trials have identified weight loss in HNC patients as an important risk factor for geometric shifts of TVs and OAR during treatment and as a main indication for replanning. [16][17][18][19] There is a widely acknowledged concern that TVs may experience dose inhomogeneities, creating cold spots that have been associated with worse local control in non-randomized cohorts. 20,21 If ART could address these inhomogeneities, the occurrence of cold spots could be minimized, potentially leading to a reduction of in-field failure rates.…”
Section: During Radiotherapy and Their Dosimetric Consequencesmentioning
confidence: 99%